176 related articles for article (PubMed ID: 34108383)
21. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
22. Interventions for preventing late postnatal mother-to-child transmission of HIV.
Horvath T; Madi BC; Iuppa IM; Kennedy GE; Rutherford G; Read JS
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006734. PubMed ID: 19160297
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.
Gray GE; Urban M; Chersich MF; Bolton C; van Niekerk R; Violari A; Stevens W; McIntyre JA;
AIDS; 2005 Aug; 19(12):1289-97. PubMed ID: 16052084
[TBL] [Abstract][Full Text] [Related]
24. Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial.
Stranix-Chibanda L; Tierney C; Sebikari D; Aizire J; Dadabhai S; Zanga A; Mukwasi-Kahari C; Vhembo T; Violari A; Theron G; Moodley D; George K; Fan B; Sommer MJ; Browning R; Mofenson LM; Shepherd J; Nelson B; Fowler MG; Siberry GK;
PLoS One; 2021; 16(2):e0246272. PubMed ID: 33544759
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of postpartum HIV superinfection and mother-to-child transmission.
Redd AD; Wendel SK; Longosz AF; Fogel JM; Dadabhai S; Kumwenda N; Sun J; Walker MP; Bruno D; Martens C; Eshleman SH; Porcella SF; Quinn TC; Taha TE
AIDS; 2015 Jul; 29(12):1567-73. PubMed ID: 26244396
[TBL] [Abstract][Full Text] [Related]
26. Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission.
Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Njiri F; John-Stewart GC
J Acquir Immune Defic Syndr; 2007 Dec; 46(4):472-8. PubMed ID: 18077838
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.
Coovadia HM; Brown ER; Fowler MG; Chipato T; Moodley D; Manji K; Musoke P; Stranix-Chibanda L; Chetty V; Fawzi W; Nakabiito C; Msweli L; Kisenge R; Guay L; Mwatha A; Lynn DJ; Eshleman SH; Richardson P; George K; Andrew P; Mofenson LM; Zwerski S; Maldonado Y;
Lancet; 2012 Jan; 379(9812):221-8. PubMed ID: 22196945
[TBL] [Abstract][Full Text] [Related]
28. CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinatal HIV prevention.
Dorton BJ; Mulindwa J; Li MS; Chintu NT; Chibwesha CJ; Mbewe F; Frenkel LM; Stringer JS; Chi BH
BJOG; 2011 Mar; 118(4):495-9. PubMed ID: 21199294
[TBL] [Abstract][Full Text] [Related]
29. Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants.
Boyce CL; Sils T; Ko D; Wong-On-Wing A; Beck IA; Styrchak SM; DeMarrais P; Tierney C; Stranix-Chibanda L; Flynn PM; Taha TE; Owor M; Fowler MG; Frenkel LM
Clin Infect Dis; 2022 Jun; 74(11):2001-2009. PubMed ID: 34467974
[TBL] [Abstract][Full Text] [Related]
30. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Brocklehurst P; Volmink J
Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
[TBL] [Abstract][Full Text] [Related]
31. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
[TBL] [Abstract][Full Text] [Related]
32. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Brocklehurst P; Volmink J
Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666
[TBL] [Abstract][Full Text] [Related]
33. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
34. Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.
Makokha EP; Songok EM; Orago AA; Koech DK; Chemtai AK; Kobayashi N; Mpoke S; Tukei PM; Andayi FA; Lihana RW; Adungo NI; Vulule JM
East Afr Med J; 2002 Nov; 79(11):567-73. PubMed ID: 12630488
[TBL] [Abstract][Full Text] [Related]
35. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
[TBL] [Abstract][Full Text] [Related]
36. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
Lallemant M; Jourdain G; Le Coeur S; Mary JY; Ngo-Giang-Huong N; Koetsawang S; Kanshana S; McIntosh K; Thaineua V;
N Engl J Med; 2004 Jul; 351(3):217-28. PubMed ID: 15247338
[TBL] [Abstract][Full Text] [Related]
37. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
38. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.
Chasela CS; Hudgens MG; Jamieson DJ; Kayira D; Hosseinipour MC; Kourtis AP; Martinson F; Tegha G; Knight RJ; Ahmed YI; Kamwendo DD; Hoffman IF; Ellington SR; Kacheche Z; Soko A; Wiener JB; Fiscus SA; Kazembe P; Mofolo IA; Chigwenembe M; Sichali DS; van der Horst CM;
N Engl J Med; 2010 Jun; 362(24):2271-81. PubMed ID: 20554982
[TBL] [Abstract][Full Text] [Related]
39. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya.
Okonji JA; Zeh C; Weidle PJ; Williamson J; Akoth B; Masaba RO; Fowler MG; Thomas TK
J Acquir Immune Defic Syndr; 2012 Oct; 61(2):249-57. PubMed ID: 22692094
[TBL] [Abstract][Full Text] [Related]
40. Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding.
Brummel SS; Taha TE; Angelidou KN; Saidi F; Atuhaire P; Dula D; Moodley D; Matubu A; Chareka G; Nevrekar N; Vhembo T; Fairlie L; Theron G; Mlay P; George K; Basar M; Chakhtoura N; Browning R; Fowler MG; Currier JS;
J Acquir Immune Defic Syndr; 2021 Apr; 86(4):450-454. PubMed ID: 33273210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
